Four novel rare mutations of PLA2G6 in Chinese population with Parkinson's disease

Parkinsonism and Related Disorders

Volumn 19, Issue 1, 2013, Pages 21-26

  Gui, Ya Xing ^a   Xu, Zhong Ping ^b   Wen Lv, ^a   Liu, Hong Mei ^b   Zhao, Jin Jia ^a   Hu, Xing Yue ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

Author keywords

Chinese populations; Mutations; Parkinson's diseases; Phospholipase; PLA2G6

Indexed keywords

PHOSPHOLIPASE A2 GROUP VI; PHOSPHOLIPID;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CHINA; CHINESE; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ACTIVITY; ENZYME INHIBITION; ETHNIC GROUP; EXON; FEMALE; FRAMESHIFT MUTATION; GENETIC IDENTIFICATION; GENETIC SCREENING; GENETIC VARIABILITY; HETEROZYGOSITY; HUMAN; LIPID HYDROLYSIS; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PARKINSON DISEASE; PATHOGENESIS; PLA2G6 GENE; PRIORITY JOURNAL;

AGE OF ONSET; AGED; AMINO ACID SEQUENCE; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GROUP VI PHOSPHOLIPASES A2; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; PARKINSON DISEASE; PHOSPHOLIPASES A2;

EID: 84871526963     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2012.07.016     Document Type: Article

References (29)

1. Singleton A., Gwinn-Hardy K. Parkinson's disease and dementia with Lewy bodies: a difference in dose?. Lancet 2004, 364:1105-1107.
2. Samii A., Nutt J.G., Ransom B.R. Parkinson's disease. Lancet 2004, 363:1783-1793.
3. Khateeb S., Flusser H., Ofir R., Shelef I., Narkis G., Vardi G., et al. PLA2G6 mutation underlies infantile neuroaxonal dystrophy. Am J Hum Genet 2006, 79:942-948.
4. Morgan N.V., Westaway S.K., Morton J.E., Gregory A., Gissen P., Sonek S., et al. PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron. Nat Genet 2006, 38:752-754.
5. Paisan-Ruiz C., Bhatia K.P., Li A., Hernandez D., Davis M., Wood N.W., et al. Characterization of PLA2G6 as a locus for dystonia-parkinsonism. Ann Neurol 2009, 65:19-23.
6. Tan E.K., Ho P., Tan L., Prakash K.M., Zhao Y. PLA2G6 mutations and Parkinson's disease. Ann Neurol 2010, 67:148.
7. Tomiyama H., Yoshino H., Ogaki K., Li L., Yamashita C., Li Y., et al. PLA2G6 variant in Parkinson's disease. J Hum Genet 2011, 56:401-403.
8. Kauther K.M., Hoft C., Rissling I., Oertel W.H., Moller J.C. The PLA2G6 gene in early-onset Parkinson's disease. Mov Disord 2011, 26:2415-2417.
9. Paisan-Ruiz C., Li A., Schneider S.A., Holton J.L., Johnson R., Kidd D., et al. Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations. Neurobiol Aging 2012, 33:814-823.
10. Tang J., Kriz R.W., Wolfman N., Shaffer M., Seehra J., Jones S.S. A novel cytosolic calcium-independent phospholipase A2 contains eight ankyrin motifs. J Biol Chem 1997, 272:8567-8575.
11. Engel L.A., Jing Z., O'Brien D.E., Sun M., Kotzbauer P.T. Catalytic function of PLA2G6 is impaired by mutations associated with infantile neuroaxonal dystrophy but not dystonia-parkinsonism. PLoS One 2010, 5:e12897.
12. Lu C.S., Lai S.C., Wu R.M., Weng Y.H., Huang C.L., Chen R.S., et al. PLA2G6 mutations in PARK14-linked young-onset parkinsonism and sporadic Parkinson's disease. Am J Med Genet B Neuropsychiatr Genet 2011, 159B:183-191.
13. Sun G.Y., Xu J., Jensen M.D., Simonyi A. Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases. J Lipid Res 2004, 45:205-213.
14. Ghosh M., Tucker D.E., Burchett S.A., Leslie C.C. Properties of the group IV phospholipase A2 family. Prog Lipid Res 2006, 45:487-510.
15. Shimizu T., Ohto T., Kita Y. Cytosolic phospholipase A2: biochemical properties and physiological roles. IUBMB Life 2006, 58:328-333.
16. Shinzawa K., Sumi H., Ikawa M., Matsuoka Y., Okabe M., Sakoda S., et al. Neuroaxonal dystrophy caused by group VIA phospholipase A2 deficiency in mice: a model of human neurodegenerative disease. J Neurosci 2008, 28:2212-2220.
17. Wada H., Yasuda T., Miura I., Watabe K., Sawa C., Kamijuku H., et al. Establishment of an improved mouse model for infantile neuroaxonal dystrophy that shows early disease onset and bears a point mutation in Pla2g6. Am J Pathol 2009, 175:2257-2263.
18. Deuschl G., Bain P., Brin M. Consensus statement of the movement disorder society on tremor. Ad hoc scientific committee. Mov Disord 1998, 13:2-23.
19. Bruggenwirth H.T., Boehmer A.L., Ramnarain S., Verleun-Mooijman M.C., Satijn D.P., Trapman J., et al. Molecular analysis of the androgen-receptor gene in a family with receptor-positive partial androgen insensitivity: an unusual type of intronic mutation. Am J Hum Genet 1997, 61:1067-1077.
20. Fujimaru M., Tanaka A., Choeh K., Wakamatsu N., Sakuraba H., Isshiki G. Two mutations remote from an exon/intron junction in the beta-hexosaminidase beta-subunit gene affect 3'-splice site selection and cause Sandhoff disease. Hum Genet 1998, 103:462-469.
21. Yu C., Meng X., Zhang S., Zhao G., Hu L., Kong X. A 3-nucleotide deletion in the polypyrimidine tract of intron 7 of the DFNA5 gene causes nonsyndromic hearing impairment in a Chinese family. Genomics 2003, 82:575-579.
22. Cartegni L., Chew S.L., Krainer A.R. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 2002, 3:285-298.
23. Chamary J.V., Parmley J.L., Hurst L.D. Hearing silence: non-neutral evolution at synonymous sites in mammals. Nat Rev Genet 2006, 7:98-108.
24. Itzkovitz S., Alon U. The genetic code is nearly optimal for allowing additional information within protein-coding sequences. Genome Res 2007, 17:405-412.
25. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
26. Hattori N., Mizuno Y. Pathogenetic mechanisms of Parkin in Parkinson's disease. Lancet 2004, 364:722-724.
27. Bower M.A., Bushara K., Dempsey M.A., Das S., Tuite P.J. Novel mutations in siblings with later-onset PLA2G6-associated neurodegeneration (PLAN). Mov Disord 2011, 26:1768-1769.
28. Klein C., Lohmann-Hedrich K., Rogaeva E., Schlossmacher M.G., Lang A.E. Deciphering the role of heterozygous mutations in genes associated with parkinsonism. Lancet Neurol 2007, 6:652-662.
29. Hedrich K., Marder K., Harris J., Kann M., Lynch T., Meija-Santana H., et al. Evaluation of 50 probands with early-onset Parkinson's disease for Parkin mutations. Neurology 2002, 58:1239-1246.